Skip to main content
STOKHealthcare

Stoke Therapeutics Inc (STOK) Insider Trading

In the last 90 days, 3 Stoke Therapeutics Inc (STOK) insiders reported no open-market purchases and 7 sales totaling $1,069,306. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 2, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 2, 2026Jonathan AllanGENERAL COUNSEL & CORP SECSale627$26.33$16,509
Oct 1, 2026Barry TichoCHIEF MEDICAL OFFICERSale1,051$26.16$27,494
Sep 1, 2026Barry TichoCHIEF MEDICAL OFFICERSale5,545$30.67$170,061
Aug 18, 2026Jonathan AllanGENERAL COUNSEL & CORP SECSale2,861$32.03$91,640
Aug 18, 2026Barry TichoCHIEF MEDICAL OFFICERSale4,767$32.03$152,690
Aug 18, 2026Edward M. Md KayeDirectorSale12,567$32.03$402,529
Aug 3, 2026Barry TichoCHIEF MEDICAL OFFICERSale7,176$29.04$208,385
Jul 1, 2026Barry TichoCHIEF MEDICAL OFFICERSale7,228$32.66$236,068
Jun 16, 2026Jonathan AllanGENERAL COUNSEL & CORP SECSale1,457$29.95$43,637
Jun 1, 2026Barry TichoCHIEF MEDICAL OFFICERSale1,795$30.58$54,891

Common questions

STOK insider trading FAQ

Are STOK insiders buying or selling?
Over the last 90 days, STOK insiders were net sellers, reporting $0.00 of open-market purchases and $1,069,306 of sales.
When was the last STOK insider purchase?
No open-market insider purchase of Stoke Therapeutics Inc stock was reported in the last 90 days.
Where does STOK insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Stoke Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.